AzTrials
AzTrials

Cardiorespiratory ResponsesNCT03946215

Cardiorespiratory Responses to Treadmill Running at Different Slopes

A study testing Each participant will perform: in people with Cardiorespiratory Responses and Well-trained Athletes, run by University Hospital, Strasbourg, France at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is: i) to determine if maximal oxygen uptake in downhill running is significantly different versus flat or uphill running, and ii) to compare cardiorespiratory and muscle fatigue responses to uphill vs flat and downhill running at similar running velocity and similar metabolic power. Read more about this study

Who is it for?
Ages 18 to 60 years, men onlyHealthy volunteers can take part
What is being tested?
Each participant will perform:
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteFrance
Study dates
1 Sep 2018to 17 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • to be a well-trained runner with a VO2max > à 55 ml/kg/min
  • nonsmoker or stopped smoking for 5 years
  • BMI < 25
  • affiliation to the social health insurance scheme
  • signing an informed consent form.

Who cannot join

  • impossibility to give the subject enlightened information (subject in emergency situation, difficulties in understanding the study, ...);
  • subject under the protection of justice
  • subject under guardianship or curatorship
  • contraindication to the practice of physical and sport activities
  • lower limbs musculotendinous or articular problems
  • respiratory, cardiovascular or metabolic pathology
  • drug treatment in progress and impossibility to stop it within 7 days before the beginning of the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • Les Hôpitaux Universitaires de Strasbourg

    Strasbourg, 67091

Other trials in France

About this study

Official title: Comparison of Cardiorespiratory Responses to Treadmill Running at Different Slopes in Well-trained Athletes

The purpose of this study is: i) to determine if maximal oxygen uptake in downhill running is significantly different versus flat or uphill running, and ii) to compare cardiorespiratory and muscle fatigue responses to uphill vs flat and downhill running at similar running velocity and similar metabolic power. The investigators hypothesized that maximal oxygen uptake will be lower in downhill running. The investigators also anticipate attenuated cardiorespiratory and muscle fatigue responses to downhill running when compared to flat or uphill running performed at similar velocity but not when the comparison is done at similar metabolic power.

Being tested
Each participant will perform:

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Each participant will perform:Other

    Part 1: Maximal incremental tests will require running at fixed slopes (+15%, 0% -15%) for stages (2min duration) of increasing velocities (0.5, 1 and 1.5 km/h) Part two: submaximal running tests will require running at constant velocity (80% VO2max uphill; 80%VO2max downhill and downhill at similar velocity as uphill)

Study groups in NCT03946215
Study groupRoleWhat they receive
well-trained athletesExperimentalA cardiorespiratory stress test
Receives: Other: Each participant will perform:

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak oxygen

    The peak oxygen uptake will be collected during downhill, flat and uphill running

    Measured: 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2019
  2. Study start1 Sep 2018
  3. Primary completion17 Dec 2018
  4. Study completion17 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03946215
Sponsor's protocol ID
7038
Status last verified
Sep 2025
First submitted
31 Aug 2018
Last updated
1 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Lemire M, Hureau TJ, Remetter R, Geny B, Kouassi BYL, Lonsdorfer E, Isner-Horobeti ME, Favret F, Dufour SP. Trail Runners Cannot Reach V O2max during a Maximal Incremental Downhill Test. Med Sci Sports Exerc. 2020 May;52(5):1135-1143. doi: 10.1249/MSS.0000000000002240.

    PubMed 31815832

Questions about this trial

What is this clinical trial studying?

A study testing Each participant will perform: in people with Cardiorespiratory Responses and Well-trained Athletes, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak oxygen (time frame: 15 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03946215, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in